Target Audience

This activity has been designed to meet the educational needs of physicians, pharmacists, and registered nurses/advanced practice providers involved in the care of patients with inflammatory bowel disease.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Select the most appropriate management options for patients based on disease and patient characteristics
  • Formulate inflammatory bowel disease (IBD) treatment plans that address the needs of special populations, such as, the elderly, pregnant patients, or those with cancer
  • Appropriately monitor drug efficacy and patient response using therapeutic drug monitoring and perform routine health maintenance screening
  • Compare the mechanisms of action, safety, and efficacy of newly approved and investigational agents in late-stage development with traditional therapies for IBD and apply this information to clinical decision making

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 5.75 contact hour(s) (0.575 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-20-1023-L01-P

Type of Activity: Knowledge

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 5.7 contact hours. Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined. 

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Americans with Disabilities Act 

Event staff will be glad to assist you with any special needs 

(i.e., physical, dietary, etc). 

Please contact Kelly Fitzgerald at (847) 827-0404

*prior to live event

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and the Crohn’s & Colitis Foundation. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.